As a regulator involving in circadian rhythm, the finding of RORα as a critical OSCC suppressor and potentially controlled by a large number of miRNAs might provide clues to further understand OSCC development and progression and develop anti-OSCC therapies, as well as to understand the clinical link between circadian rhythm and cancer. This evidence concerns the gene RORA and cancer.